Hookipa, Merck partner for Phase II HB-200/Keytruda combination trial
Hookipa Pharma has signed a clinical collaboration and supply agreement with Merck to assess HB-200 in combination with Keytruda (pembrolizumab) in patients with advanced head and neck squamous